This transcript has been edited for clarity. Silvio Inzucchi, MD: Welcome to Medscape InDiscussion. I'm Dr Silvio Inzucchi, and today we'll be talking about treating type 2 diabetes in minority ...

This transcript has been edited for clarity. Silvio Inzucchi, MD: Welcome to Medscape InDiscussion. I'm Dr Silvio Inzucchi. This is episode number 6, and we've saved the best for last. We'll be ...

Please provide your email address to receive an email when new articles are posted on . For Silvio E. Inzucchi, MD, a simple question from a patient who underwent coronary artery bypass graft surgery ...

Yale's Silvio Inzucchi, MD, who has been involved in groundbreaking trials with SGLT2 inhibitors for the past decade, shared data that show patients who did not have type 2 diabetes (T2D) when they ...

Dr. Silvio Inzucchi, professor of medicine, is the winner of this year’s annual David J. Leffell Prize for Clinical Excellence. The prize is given to individuals who demonstrate the highest level of ...

New Haven, Conn. - The most popular treatment for type 2 diabetes, metformin, may be safer for patients with mild to moderate kidney disease than guidelines suggest, according to a new, systematic ...

More details are revealed on the first diabetes drug shown to have a cardioprotective benefit, but Yale's Silvio Inzucchi was cautious about assuming the effect applies to the entire SGLT2 inhibitor ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Lifestyle or medical therapy in prediabetes to reduce ...

ORLANDO (Reuters) - Eli Lilly's new diabetes drug Jardiance significantly cut the risk of heart-related death and hospitalization for heart failure in patients with type 2 diabetes who are at high ...

TRENTON, N.J. (AP) — Jardiance sharply reduced chances of dying in diabetic patients at high risk of heart complications, a study shows, making the Type 2 diabetes medication the first shown to ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

ORLANDO – Eli Lilly's new diabetes drug Jardiance significantly cut the risk of heart-related death and hospitalization for heart failure in patients with type 2 diabetes who are at high risk for ...